E-LIB Suche - Ergebnisse für: Kruse, C. G.

1

Recreating Observed Convection‐Generated Gravity Waves From..:

Kruse, C. G. ; Alexander, M. J. ; Bramberger, M....
Journal of Advances in Modeling Earth Systems. 16 (2024) 4 - p. , 2024

Link: https://doi.org/10.1029/..

2

The selective 5-HT 6 receptor antagonist SLV has putative c..:

de Bruin, N.M.W.J. ; van Loevezijn, A. ; Wicke, K.M....
Neurobiology of Learning and Memory. 133 (2016) - p. 100-117 , 2016

Link: https://doi.org/10.1016/..

3

A novel highly selective 5-HT6 receptor antagonist attenuat..:

de Bruin, N.M.W.J. ; McCreary, A.C. ; van Loevezijn, A....
Behavioural Brain Research. 236 (2013) - p. 157-165 , 2013

Link: https://doi.org/10.1016/..

4

Two novel 5-HT6 receptor antagonists ameliorate scopolamine..:

de Bruin, N.M.W.J. ; Prickaerts, J. ; van Loevezijn, A....
Neurobiology of Learning and Memory. 96 (2011) 2 - p. 392-402 , 2011

Link: https://doi.org/10.1016/..

5

SLV330, a cannabinoid CB1 receptor antagonist, attenuates e..:

de Bruin, N.M.W.J. ; Lange, J.H.M. ; Kruse, C.G....
Behavioural Brain Research. 217 (2011) 2 - p. 408-415 , 2011

Link: https://doi.org/10.1016/..

6

SLV330, a cannabinoid CB1 receptor antagonist, ameliorates ..:

de Bruin, N.M.W.J. ; Prickaerts, J. ; Lange, J.H.M....
Neurobiology of Learning and Memory. 93 (2010) 4 - p. 522-531 , 2010

Link: https://doi.org/10.1016/..

7

Towards drugs of the future: key issues in lead finding and..

Solvay Pharmaceuticals Conferences, v. 9

Kruse, C. G ; Timmerman, H , 2008

Link: https://search.ebscohost..

8

5-HT2 receptors differentially modulate dopamine-mediated a..:

Olijslagers, J.E. ; Werkman, T.R. ; McCreary, A.C....
Neuropharmacology. 46 (2004) 4 - p. 504-510 , 2004

Link: https://doi.org/10.1016/..

9

DU127090: A novel partial dopamine agonist with antipsychot..:

Yang, H. ; Casey, D.E. ; Feenstra, R.W...
Schizophrenia Research. 60 (2003) 1 - p. 370 , 2003

Link: https://doi.org/10.1016/..

10

SLV310, a molecule combining potent dopamine D2 receptor an..:

Kruse, C.G. ; Tuinstra, T. ; Herremans, A....
Schizophrenia Research. 60 (2003) 1 - p. 110 , 2003

Link: https://doi.org/10.1016/..

11

DU127090: A novel partial dopamine agonist with antipsychot..:

van Kolfschoten, A. ; Hesselink, M.B. ; Long, S.K....
Schizophrenia Research. 60 (2003) 1 - p. 117 , 2003

Link: https://doi.org/10.1016/..

12

DU127090: A novel partial dopamine agonist with antipsychot..:

Arnt, J. ; Hesselink, M.B. ; Didriksen, M....
Schizophrenia Research. 60 (2003) 1 - p. 104 , 2003

Link: https://doi.org/10.1016/..

13

DU 127090: A novel partial dopamine agonist with antipsycho..:

Hesselink, M.B. ; van Vliet, B.J. ; Ronken, E....
Schizophrenia Research. 60 (2003) 1 - p. 108 , 2003

Link: https://doi.org/10.1016/..

14

SLV310, a molecule combining potent dopamine D2 receptor an..:

Tuinstra, T. ; Herremans, A.H.J. ; Van der Heyden, J.A.M....
European Neuropsychopharmacology. 12 (2002) - p. 296 , 2002

Link: https://doi.org/10.1016/..

15

SLV310, a molecule combining potent dopamine D2 receptor an..:

Hesselink, M.B. ; Van Vliet, B. ; Kruse, C.G..
European Neuropsychopharmacology. 12 (2002) - p. 319 , 2002

Link: https://doi.org/10.1016/..